Mid-Infrared Imaging Is Able to Characterize and Separate Cancer Cell Lines.
Endre KontsekA PestiM BjörnstedtT ÜvegesE SzabóT GarayP GordonS GergelyA KissPublished in: Pathology oncology research : POR (2020)
Malignancies are still responsible for a large share of lethalities. Macroscopical evaluation of the surgical resection margins is uncertain. Big data based imaging approaches have emerged in the recent decade (mass spectrometry, two-photon microscopy, infrared and Raman spectroscopy). Indocianine green labelled MS is the most common approach, however, label free mid-infrared imaging is more promising for future practical application. We aimed to identify and separate different transformed (A-375, HT-29) and non-transformed (CCD986SK) cell lines by a label-free infrared spectroscopy method. Our approach applied a novel set-up for label-free mid-infrared range classification method. Transflection spectroscopy was used on aluminium coated glass slides. Both whole range spectra (4000-648 cm-1) and hypersensitive fingerprint regions (1800-648 cm-1) were tested on the imaged areas of cell lines fixed in ethanol. Non-cell spectra were possible to be excluded based on mean transmission values being above 90%. Feasibility of a mean transmission based spectra filtering method with principal component analysis and linear discriminant analysis was shown to separate cell lines representing different tissue types. Fingerprint region resulted the best separation of cell lines spectra with accuracy of 99.84% at 70-75 mean transmittance range. Our approach in vitro was able to separate unique cell lines representing different tissues of origin. Proper data handling and spectra processing are key steps to achieve the adaptation of this dye-free technique for intraoperative surgery. Further studies are urgently needed to test this novel, marker-free approach.
Keyphrases
- label free
- high resolution
- big data
- mass spectrometry
- density functional theory
- machine learning
- raman spectroscopy
- minimally invasive
- multiple sclerosis
- liquid chromatography
- stem cells
- squamous cell carcinoma
- gene expression
- cell therapy
- single molecule
- coronary artery disease
- photodynamic therapy
- molecular dynamics
- electronic health record
- high throughput
- fluorescence imaging
- percutaneous coronary intervention
- living cells
- coronary artery bypass